Security key
29405E406
Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB)
CUSIP: 29405E406
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 3,000
- Total 13F value
- $4,140
- Share change
- +3,000
- SEC-reported price per share
- $1.38
- Number of holders
- 1
- Value change
- +$4,140
- Number of buys
- 1
- Shares outstanding
- 2,083,186
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
ENVB full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Enveric Biosciences, Inc. SEC filings
Enveric Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29405E406
Recent filing periods:
Ownership snapshot
Top reported holders of ENVB - Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
10%
INTRACOASTAL CAPITAL, LLC
5%
Orca Capital AG
4.9%
Ayrton Capital LLC
2.9%
AdvisorShares Trust
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
10%
|
$550,925
405,092 shares
|
$0 | 30 Jun 2026 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$278,572
71,246 shares
|
+$155,982 | 27 Jan 2026 |
| Orca Capital AG |
13D/G
|
4.9%
|
$32,016
97,019 shares
|
-$22,984 | 31 Jan 2025 |
| Ayrton Capital LLC |
13D/G
|
2.9%
|
$151,157
111,145 shares
|
-$744,355 | 30 Jun 2026 |
| AdvisorShares Trust |
13D/G
|
1.7%
|
$5,601
16,974 shares
|
-$61,613 | 31 Dec 2025 |
| Lind Global Fund III LP |
13D/G
EASTON JEFF
|
1.4%
|
$70,538
51,866 shares
|
-$148,738 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
3,000
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q4 2025 Across Filers
Q4 2025 holders
0
Q2 2026 holders
1
Holder diff
1
| Investor | Q4 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend